In a recent clinal trial where relapsed B-acute lymphoblastic leukemia (B-ALL) patients were treated with CD19 CAR CIK-cells, no GvHD was observed, and the cells could be detected up to 10 months after infusion [72]. The gene discussed is CD19; the disease is precursor B-cell acute lymphoblastic leukemia.